| pubmed-article:21233194 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21233194 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:21233194 | lifeskim:mentions | umls-concept:C0031809 | lld:lifeskim |
| pubmed-article:21233194 | lifeskim:mentions | umls-concept:C0031268 | lld:lifeskim |
| pubmed-article:21233194 | lifeskim:mentions | umls-concept:C0026336 | lld:lifeskim |
| pubmed-article:21233194 | lifeskim:mentions | umls-concept:C0023903 | lld:lifeskim |
| pubmed-article:21233194 | lifeskim:mentions | umls-concept:C0046056 | lld:lifeskim |
| pubmed-article:21233194 | lifeskim:mentions | umls-concept:C1704632 | lld:lifeskim |
| pubmed-article:21233194 | lifeskim:mentions | umls-concept:C0871261 | lld:lifeskim |
| pubmed-article:21233194 | lifeskim:mentions | umls-concept:C2911692 | lld:lifeskim |
| pubmed-article:21233194 | lifeskim:mentions | umls-concept:C1706817 | lld:lifeskim |
| pubmed-article:21233194 | lifeskim:mentions | umls-concept:C0032743 | lld:lifeskim |
| pubmed-article:21233194 | lifeskim:mentions | umls-concept:C0450442 | lld:lifeskim |
| pubmed-article:21233194 | lifeskim:mentions | umls-concept:C0021439 | lld:lifeskim |
| pubmed-article:21233194 | lifeskim:mentions | umls-concept:C0054130 | lld:lifeskim |
| pubmed-article:21233194 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:21233194 | pubmed:dateCreated | 2011-1-28 | lld:pubmed |
| pubmed-article:21233194 | pubmed:abstractText | The purpose of this study was to determine the effects of 3-bromopyruvate (3-BrPA) on tumor glucose metabolism as imaged with (18)F-FDG PET/CT at multiple time points after treatment and compare them with those after intraarterial control injections of saline. | lld:pubmed |
| pubmed-article:21233194 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21233194 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21233194 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21233194 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21233194 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21233194 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21233194 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21233194 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21233194 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21233194 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21233194 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21233194 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21233194 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21233194 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21233194 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:21233194 | pubmed:issn | 1535-5667 | lld:pubmed |
| pubmed-article:21233194 | pubmed:author | pubmed-author:WahlRichard... | lld:pubmed |
| pubmed-article:21233194 | pubmed:author | pubmed-author:GeschwindJean... | lld:pubmed |
| pubmed-article:21233194 | pubmed:author | pubmed-author:ValiMustafaM | lld:pubmed |
| pubmed-article:21233194 | pubmed:author | pubmed-author:LiapiEleniE | lld:pubmed |
| pubmed-article:21233194 | pubmed:author | pubmed-author:VossenJosephi... | lld:pubmed |
| pubmed-article:21233194 | pubmed:author | pubmed-author:BuijsManonM | lld:pubmed |
| pubmed-article:21233194 | pubmed:author | pubmed-author:Prieto-Ventur... | lld:pubmed |
| pubmed-article:21233194 | pubmed:author | pubmed-author:KhwajaAfsheen... | lld:pubmed |
| pubmed-article:21233194 | pubmed:author | pubmed-author:GanapathyShan... | lld:pubmed |
| pubmed-article:21233194 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21233194 | pubmed:volume | 52 | lld:pubmed |
| pubmed-article:21233194 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21233194 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21233194 | pubmed:pagination | 225-30 | lld:pubmed |
| pubmed-article:21233194 | pubmed:dateRevised | 2011-3-30 | lld:pubmed |
| pubmed-article:21233194 | pubmed:meshHeading | pubmed-meshheading:21233194... | lld:pubmed |
| pubmed-article:21233194 | pubmed:meshHeading | pubmed-meshheading:21233194... | lld:pubmed |
| pubmed-article:21233194 | pubmed:meshHeading | pubmed-meshheading:21233194... | lld:pubmed |
| pubmed-article:21233194 | pubmed:meshHeading | pubmed-meshheading:21233194... | lld:pubmed |
| pubmed-article:21233194 | pubmed:meshHeading | pubmed-meshheading:21233194... | lld:pubmed |
| pubmed-article:21233194 | pubmed:meshHeading | pubmed-meshheading:21233194... | lld:pubmed |
| pubmed-article:21233194 | pubmed:meshHeading | pubmed-meshheading:21233194... | lld:pubmed |
| pubmed-article:21233194 | pubmed:meshHeading | pubmed-meshheading:21233194... | lld:pubmed |
| pubmed-article:21233194 | pubmed:meshHeading | pubmed-meshheading:21233194... | lld:pubmed |
| pubmed-article:21233194 | pubmed:meshHeading | pubmed-meshheading:21233194... | lld:pubmed |
| pubmed-article:21233194 | pubmed:meshHeading | pubmed-meshheading:21233194... | lld:pubmed |
| pubmed-article:21233194 | pubmed:meshHeading | pubmed-meshheading:21233194... | lld:pubmed |
| pubmed-article:21233194 | pubmed:meshHeading | pubmed-meshheading:21233194... | lld:pubmed |
| pubmed-article:21233194 | pubmed:meshHeading | pubmed-meshheading:21233194... | lld:pubmed |
| pubmed-article:21233194 | pubmed:meshHeading | pubmed-meshheading:21233194... | lld:pubmed |
| pubmed-article:21233194 | pubmed:meshHeading | pubmed-meshheading:21233194... | lld:pubmed |
| pubmed-article:21233194 | pubmed:meshHeading | pubmed-meshheading:21233194... | lld:pubmed |
| pubmed-article:21233194 | pubmed:meshHeading | pubmed-meshheading:21233194... | lld:pubmed |
| pubmed-article:21233194 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21233194 | pubmed:articleTitle | Assessment of tumoricidal efficacy and response to treatment with 18F-FDG PET/CT after intraarterial infusion with the antiglycolytic agent 3-bromopyruvate in the VX2 model of liver tumor. | lld:pubmed |
| pubmed-article:21233194 | pubmed:affiliation | Division of Interventional Radiology, Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University, Baltimore, Maryland 21287-0817, USA. | lld:pubmed |
| pubmed-article:21233194 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21233194 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:21233194 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
